CN Stock MarketDetailed Quotes

600161 Beijing Tiantan Biological Products Corporation

Watchlist

19.89
-0.33-1.63%

Market Closed Jan 3 15:00 CST

39.33BMarket Cap30.89P/E (TTM)

Beijing Tiantan Biological Products Corporation Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-5.05%4.8B

30.01%4.87B

14.82%4.75B

22.68%4.55B

20.11%5.06B

-16.43%3.75B

-3.10%4.14B

-14.25%3.71B

-11.22%4.21B

-7.70%4.49B

Notes receivable and accounts receivable

-46.27%262.19M

-86.90%119.45M

-89.43%109.58M

-90.73%94.13M

-48.28%487.98M

2.87%911.95M

8.06%1.04B

-1.11%1.02B

8.04%943.5M

8.19%886.48M

-Notes receivable

-48.62%236.76M

-88.89%98.38M

-91.02%89.51M

-92.24%76.27M

-49.34%460.8M

2.98%885.17M

6.06%997.27M

-3.42%982.63M

6.86%909.66M

7.76%859.55M

-Accounts receivable

-6.43%25.43M

-21.35%21.07M

-49.24%20.07M

-46.31%17.87M

-19.69%27.18M

-0.52%26.79M

105.86%39.54M

239.22%33.27M

53.59%33.84M

23.94%26.93M

Other receivables (including interest and dividends)

-44.26%20.53M

73.18%53.11M

14.45%36.6M

37.78%39.08M

-17.49%36.84M

-10.30%30.67M

1.48%31.98M

27.36%28.36M

162.71%44.65M

149.52%34.19M

-Accrued interest receivable

-71.50%1.02M

-5.21%2.24M

----

67.02%5.27M

9.16%3.57M

264.39%2.36M

1,142.69%4.53M

246.96%3.15M

92.98%3.27M

36.37%648.79K

-Other receivable

----

79.72%50.87M

----

-15.61%28.3M

----

18.02%25.21M

----

153.59%33.54M

Advance payment

-23.23%45.86M

81.62%43.41M

-29.57%41.4M

43.35%35.27M

37.72%59.73M

-44.48%23.9M

111.83%58.78M

20.89%24.6M

-10.62%43.37M

11.65%43.05M

Inventories

37.52%3.41B

35.33%3.14B

34.98%3.08B

21.98%2.84B

3.78%2.48B

0.25%2.32B

-1.59%2.28B

8.76%2.33B

5.24%2.39B

3.68%2.31B

Receivable financing

----

--79.42M

--156.67M

----

Other current assets

-32.29%502.68K

47.95%1.42M

-67.32%880.28K

361.09%1.26M

-51.11%742.45K

-46.43%960.79K

-2.38%2.69M

-85.78%273.67K

27.84%1.52M

-5.24%1.79M

Total current assets

5.15%8.54B

16.98%8.23B

5.11%8.02B

4.11%7.57B

6.41%8.12B

-9.39%7.03B

0.25%7.63B

-3.64%7.27B

-4.03%7.63B

-2.51%7.76B

Non Current assets

Other equity investment

-1.96%143.2M

0.00%146.06M

11.44%146.06M

25.85%146.06M

Investment real estate

-4.64%65.46M

-4.55%66.53M

-4.45%67.61M

-4.36%68.69M

-5.81%68.64M

-5.72%69.7M

-5.64%70.76M

-5.57%71.82M

-5.49%72.88M

4.83%73.93M

Fixed assets

----

10.71%2.82B

----

164.05%2.54B

----

156.55%2.48B

----

1.09%963.1M

Fixed assets liquidation

----

-26.80%539.02K

----

-81.29%736.33K

----

982.78%3.94M

Constru in process

----

23.65%2.26B

----

-9.90%1.83B

----

-5.66%1.53B

----

66.48%2.03B

Intangible assets

7.89%743.87M

57.67%723.4M

48.27%675.62M

55.53%686.88M

66.24%689.48M

16.93%458.8M

21.35%455.67M

19.04%441.63M

37.68%414.75M

29.55%392.36M

Development expenditure

8.81%382.98M

-32.72%372.94M

-26.73%385.48M

-25.54%363.59M

-10.26%351.97M

50.70%554.34M

50.80%526.1M

47.94%488.32M

59.06%392.22M

87.91%367.85M

Goodwill

0.00%173.92M

2.31%173.92M

35.95%173.92M

32.88%170M

0.00%127.93M

Long deferred expense

28.42%96.91M

62.59%101.39M

64.30%100.19M

65.70%106.67M

97.97%75.46M

61.37%62.36M

78.11%60.98M

98.84%64.38M

42.77%38.12M

49.34%38.64M

Deferred tax assets

-50.80%43.35M

-23.64%60.05M

-25.52%54.51M

-22.91%46.74M

20.63%88.11M

8.27%78.64M

9.19%73.2M

-9.53%60.63M

3.36%73.05M

-4.70%72.63M

Usufruct assets

11.24%47.69M

4.06%49.73M

0.16%47.22M

8.87%49.88M

-11.82%42.87M

-5.26%47.79M

26.91%47.15M

10.25%45.82M

6.75%48.62M

13.38%50.44M

Other non current assets

-43.41%138.76M

-83.72%143.87M

14.45%148.82M

-10.88%139.97M

1.05%245.2M

278.44%883.73M

-47.03%130.02M

-37.38%157.06M

-3.40%242.65M

21.29%233.52M

Total non current assets

8.32%7.01B

0.93%6.91B

15.11%6.78B

16.97%6.62B

22.64%6.47B

52.20%6.85B

38.72%5.89B

40.34%5.66B

44.17%5.28B

35.35%4.5B

Total assets

6.56%15.55B

9.06%15.14B

9.46%14.79B

9.74%14.19B

13.05%14.6B

13.20%13.88B

14.02%13.51B

11.67%12.93B

11.16%12.91B

8.64%12.26B

Liabilities

Current liabilities

Notes payable and accounts payable

-41.59%94.15M

22.27%119.63M

85.17%160.09M

158.11%179.1M

79.85%161.19M

-3.93%97.84M

37.93%86.45M

-5.86%69.39M

29.23%89.62M

39.18%101.85M

-Notes payable

-64.24%25.09M

50.99%46.09M

2,341.62%82.6M

213,872.01%104.7M

197,566.68%70.17M

12,897.40%30.52M

776.31%3.38M

-85.08%48.93K

-98.84%35.5K

-91.95%234.84K

-Accounts payable

-24.12%69.06M

9.24%73.54M

-6.72%77.49M

7.30%74.4M

1.59%91.01M

-33.75%67.32M

33.36%83.07M

-5.50%69.34M

35.16%89.59M

44.63%101.61M

Contract liabilities

-23.65%419.97M

53.76%490.12M

28.68%475.81M

21.64%356.07M

92.01%550.05M

15.26%318.75M

18.31%369.76M

35.95%292.72M

-12.22%286.47M

-20.41%276.54M

Advance receipts

1,027.81%3.8M

--2.91M

--2.03M

--1.18M

--336.65K

----

Salaries payable

40.32%340.18M

43.57%233.6M

23.64%118.16M

20.90%23.86M

7.41%242.43M

-3.87%162.72M

-8.33%95.57M

-24.04%19.74M

10.20%225.69M

12.74%169.26M

Taxs payable

-15.26%121.74M

13.54%150.15M

16.21%125.5M

-15.01%116.8M

44.24%143.66M

35.89%132.24M

96.80%107.99M

26.83%137.43M

38.36%99.6M

47.93%97.32M

Other payable (including interest and dividends)

-15.10%547.71M

-10.87%548.76M

-5.88%538.96M

15.00%574.25M

7.43%645.14M

65.53%615.66M

137.44%572.64M

95.63%499.33M

140.09%600.51M

43.83%371.93M

-Dividend payable

1.63%105.23M

-43.59%104.38M

--103.52M

1.81%102.65M

-33.05%103.54M

34.76%185.05M

----

--100.83M

--154.65M

--137.32M

-Other payable

----

3.20%444.37M

----

83.54%430.61M

----

56.13%398.5M

----

-9.27%234.61M

Non current liabilities due within one year

-89.59%11.24M

-89.32%13.85M

-87.92%14.71M

-85.50%17.95M

-16.37%107.96M

-0.16%129.73M

-1.27%121.77M

-0.68%123.81M

9.39%129.09M

12.02%129.94M

Other current liabilities

-26.65%12.6M

4.37%16.51M

26.27%14M

-30.43%10.4M

102.34%17.17M

95.58%15.82M

20.99%11.09M

136.11%14.94M

-12.17%8.49M

-17.71%8.09M

Total current liabilities

-16.95%1.55B

6.98%1.58B

6.15%1.45B

10.56%1.28B

29.76%1.87B

27.52%1.47B

50.36%1.37B

42.96%1.16B

37.05%1.44B

13.12%1.15B

Current liabilities

Long term loan

----

-70.16%92.5M

-37.10%195M

-30.72%253.75M

-26.31%310M

Deferred tax liabilities

-19.89%27.2M

-20.06%27.84M

-30.67%28.67M

-6.55%28.85M

18.38%33.96M

72.15%34.82M

99.26%41.35M

53.32%30.87M

29.42%28.69M

-11.37%20.23M

Long term deferred income

-1.41%97.19M

-2.75%97.32M

-2.67%98.64M

-2.30%99.56M

2.28%98.58M

4.59%100.07M

9.04%101.35M

9.95%101.9M

14.43%96.39M

13.61%95.68M

Lease liabilities

37.99%28.01M

12.67%29.68M

-13.42%27.51M

-4.69%24.42M

1.67%20.3M

42.08%26.34M

93.75%31.77M

42.20%25.62M

-1.60%19.96M

-8.17%18.54M

Other non current liabilities

-69.79%1.24M

0.00%4.1M

Total non current liabilities

-38.41%153.64M

-56.69%156.07M

-63.90%156.06M

-62.99%154.07M

-45.67%249.44M

-19.67%360.34M

-13.61%432.33M

-16.95%416.25M

-16.75%459.14M

-18.75%448.55M

Total liabilities

-19.47%1.71B

-5.54%1.73B

-10.70%1.61B

-8.89%1.43B

11.52%2.12B

14.32%1.83B

27.63%1.8B

20.05%1.57B

18.53%1.9B

1.94%1.6B

Shareholders equity

Paid-in capital

20.00%1.98B

0.00%1.65B

20.00%1.65B

Capital reserve funds

-11.80%2.46B

0.00%2.79B

-8.95%2.79B

Surplus reserve funds

0.90%261.76M

2.29%259.43M

1.22%253.62M

Retained profit

21.18%5.94B

22.56%5.61B

24.77%5.44B

25.03%5.12B

28.24%4.9B

27.03%4.58B

25.11%4.36B

21.95%4.1B

20.97%3.82B

22.73%3.61B

Other composite income

0.00%-104.21K

Shareholders equity without minority interests

10.84%10.64B

11.16%10.32B

11.94%10.14B

11.68%9.82B

12.74%9.6B

11.81%9.28B

10.77%9.06B

9.23%8.8B

8.48%8.52B

8.79%8.3B

Minority interests

11.42%3.21B

11.71%3.09B

14.66%3.05B

14.50%2.93B

15.25%2.88B

17.33%2.77B

17.33%2.66B

15.60%2.56B

15.45%2.5B

13.11%2.36B

Total shareholder equity

10.97%13.85B

11.28%13.41B

12.56%13.19B

12.32%12.75B

13.31%12.48B

13.03%12.05B

12.19%11.72B

10.60%11.36B

9.98%11.01B

9.72%10.66B

Total liabilityies and equity

6.56%15.55B

9.06%15.14B

9.46%14.79B

9.74%14.19B

13.05%14.6B

13.20%13.88B

14.02%13.51B

11.67%12.93B

11.16%12.91B

8.64%12.26B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-5.05%4.8B	30.01%4.87B	14.82%4.75B	22.68%4.55B	20.11%5.06B	-16.43%3.75B	-3.10%4.14B	-14.25%3.71B	-11.22%4.21B	-7.70%4.49B
Notes receivable and accounts receivable	-46.27%262.19M	-86.90%119.45M	-89.43%109.58M	-90.73%94.13M	-48.28%487.98M	2.87%911.95M	8.06%1.04B	-1.11%1.02B	8.04%943.5M	8.19%886.48M
-Notes receivable	-48.62%236.76M	-88.89%98.38M	-91.02%89.51M	-92.24%76.27M	-49.34%460.8M	2.98%885.17M	6.06%997.27M	-3.42%982.63M	6.86%909.66M	7.76%859.55M
-Accounts receivable	-6.43%25.43M	-21.35%21.07M	-49.24%20.07M	-46.31%17.87M	-19.69%27.18M	-0.52%26.79M	105.86%39.54M	239.22%33.27M	53.59%33.84M	23.94%26.93M
Other receivables (including interest and dividends)	-44.26%20.53M	73.18%53.11M	14.45%36.6M	37.78%39.08M	-17.49%36.84M	-10.30%30.67M	1.48%31.98M	27.36%28.36M	162.71%44.65M	149.52%34.19M
-Accrued interest receivable	-71.50%1.02M	-5.21%2.24M	----	67.02%5.27M	9.16%3.57M	264.39%2.36M	1,142.69%4.53M	246.96%3.15M	92.98%3.27M	36.37%648.79K
-Other receivable	----	79.72%50.87M	----	----	----	-15.61%28.3M	----	18.02%25.21M	----	153.59%33.54M
Advance payment	-23.23%45.86M	81.62%43.41M	-29.57%41.4M	43.35%35.27M	37.72%59.73M	-44.48%23.9M	111.83%58.78M	20.89%24.6M	-10.62%43.37M	11.65%43.05M
Inventories	37.52%3.41B	35.33%3.14B	34.98%3.08B	21.98%2.84B	3.78%2.48B	0.25%2.32B	-1.59%2.28B	8.76%2.33B	5.24%2.39B	3.68%2.31B
Receivable financing	----	----	----	----	----	----	--79.42M	--156.67M	----	----
Other current assets	-32.29%502.68K	47.95%1.42M	-67.32%880.28K	361.09%1.26M	-51.11%742.45K	-46.43%960.79K	-2.38%2.69M	-85.78%273.67K	27.84%1.52M	-5.24%1.79M
Total current assets	5.15%8.54B	16.98%8.23B	5.11%8.02B	4.11%7.57B	6.41%8.12B	-9.39%7.03B	0.25%7.63B	-3.64%7.27B	-4.03%7.63B	-2.51%7.76B
Non Current assets
Other equity investment	-1.96%143.2M	-1.96%143.2M	0.00%146.06M	0.00%146.06M	0.00%146.06M	0.00%146.06M	0.00%146.06M	0.00%146.06M	11.44%146.06M	25.85%146.06M
Investment real estate	-4.64%65.46M	-4.55%66.53M	-4.45%67.61M	-4.36%68.69M	-5.81%68.64M	-5.72%69.7M	-5.64%70.76M	-5.57%71.82M	-5.49%72.88M	4.83%73.93M
Fixed assets	----	10.71%2.82B	----	----	----	164.05%2.54B	----	156.55%2.48B	----	1.09%963.1M
Fixed assets liquidation	----	-26.80%539.02K	----	----	----	-81.29%736.33K	----	----	----	982.78%3.94M
Constru in process	----	23.65%2.26B	----	----	----	-9.90%1.83B	----	-5.66%1.53B	----	66.48%2.03B
Intangible assets	7.89%743.87M	57.67%723.4M	48.27%675.62M	55.53%686.88M	66.24%689.48M	16.93%458.8M	21.35%455.67M	19.04%441.63M	37.68%414.75M	29.55%392.36M
Development expenditure	8.81%382.98M	-32.72%372.94M	-26.73%385.48M	-25.54%363.59M	-10.26%351.97M	50.70%554.34M	50.80%526.1M	47.94%488.32M	59.06%392.22M	87.91%367.85M
Goodwill	0.00%173.92M	0.00%173.92M	0.00%173.92M	0.00%173.92M	2.31%173.92M	35.95%173.92M	35.95%173.92M	35.95%173.92M	32.88%170M	0.00%127.93M
Long deferred expense	28.42%96.91M	62.59%101.39M	64.30%100.19M	65.70%106.67M	97.97%75.46M	61.37%62.36M	78.11%60.98M	98.84%64.38M	42.77%38.12M	49.34%38.64M
Deferred tax assets	-50.80%43.35M	-23.64%60.05M	-25.52%54.51M	-22.91%46.74M	20.63%88.11M	8.27%78.64M	9.19%73.2M	-9.53%60.63M	3.36%73.05M	-4.70%72.63M
Usufruct assets	11.24%47.69M	4.06%49.73M	0.16%47.22M	8.87%49.88M	-11.82%42.87M	-5.26%47.79M	26.91%47.15M	10.25%45.82M	6.75%48.62M	13.38%50.44M
Other non current assets	-43.41%138.76M	-83.72%143.87M	14.45%148.82M	-10.88%139.97M	1.05%245.2M	278.44%883.73M	-47.03%130.02M	-37.38%157.06M	-3.40%242.65M	21.29%233.52M
Total non current assets	8.32%7.01B	0.93%6.91B	15.11%6.78B	16.97%6.62B	22.64%6.47B	52.20%6.85B	38.72%5.89B	40.34%5.66B	44.17%5.28B	35.35%4.5B
Total assets	6.56%15.55B	9.06%15.14B	9.46%14.79B	9.74%14.19B	13.05%14.6B	13.20%13.88B	14.02%13.51B	11.67%12.93B	11.16%12.91B	8.64%12.26B
Liabilities
Current liabilities
Notes payable and accounts payable	-41.59%94.15M	22.27%119.63M	85.17%160.09M	158.11%179.1M	79.85%161.19M	-3.93%97.84M	37.93%86.45M	-5.86%69.39M	29.23%89.62M	39.18%101.85M
-Notes payable	-64.24%25.09M	50.99%46.09M	2,341.62%82.6M	213,872.01%104.7M	197,566.68%70.17M	12,897.40%30.52M	776.31%3.38M	-85.08%48.93K	-98.84%35.5K	-91.95%234.84K
-Accounts payable	-24.12%69.06M	9.24%73.54M	-6.72%77.49M	7.30%74.4M	1.59%91.01M	-33.75%67.32M	33.36%83.07M	-5.50%69.34M	35.16%89.59M	44.63%101.61M
Contract liabilities	-23.65%419.97M	53.76%490.12M	28.68%475.81M	21.64%356.07M	92.01%550.05M	15.26%318.75M	18.31%369.76M	35.95%292.72M	-12.22%286.47M	-20.41%276.54M
Advance receipts	1,027.81%3.8M	--2.91M	--2.03M	--1.18M	--336.65K	----	----	----	----	----
Salaries payable	40.32%340.18M	43.57%233.6M	23.64%118.16M	20.90%23.86M	7.41%242.43M	-3.87%162.72M	-8.33%95.57M	-24.04%19.74M	10.20%225.69M	12.74%169.26M
Taxs payable	-15.26%121.74M	13.54%150.15M	16.21%125.5M	-15.01%116.8M	44.24%143.66M	35.89%132.24M	96.80%107.99M	26.83%137.43M	38.36%99.6M	47.93%97.32M
Other payable (including interest and dividends)	-15.10%547.71M	-10.87%548.76M	-5.88%538.96M	15.00%574.25M	7.43%645.14M	65.53%615.66M	137.44%572.64M	95.63%499.33M	140.09%600.51M	43.83%371.93M
-Dividend payable	1.63%105.23M	-43.59%104.38M	--103.52M	1.81%102.65M	-33.05%103.54M	34.76%185.05M	----	--100.83M	--154.65M	--137.32M
-Other payable	----	3.20%444.37M	----	----	----	83.54%430.61M	----	56.13%398.5M	----	-9.27%234.61M
Non current liabilities due within one year	-89.59%11.24M	-89.32%13.85M	-87.92%14.71M	-85.50%17.95M	-16.37%107.96M	-0.16%129.73M	-1.27%121.77M	-0.68%123.81M	9.39%129.09M	12.02%129.94M
Other current liabilities	-26.65%12.6M	4.37%16.51M	26.27%14M	-30.43%10.4M	102.34%17.17M	95.58%15.82M	20.99%11.09M	136.11%14.94M	-12.17%8.49M	-17.71%8.09M
Total current liabilities	-16.95%1.55B	6.98%1.58B	6.15%1.45B	10.56%1.28B	29.76%1.87B	27.52%1.47B	50.36%1.37B	42.96%1.16B	37.05%1.44B	13.12%1.15B
Current liabilities
Long term loan	----	----	----	----	-70.16%92.5M	-37.10%195M	-30.72%253.75M	-30.72%253.75M	-26.31%310M	-26.31%310M
Deferred tax liabilities	-19.89%27.2M	-20.06%27.84M	-30.67%28.67M	-6.55%28.85M	18.38%33.96M	72.15%34.82M	99.26%41.35M	53.32%30.87M	29.42%28.69M	-11.37%20.23M
Long term deferred income	-1.41%97.19M	-2.75%97.32M	-2.67%98.64M	-2.30%99.56M	2.28%98.58M	4.59%100.07M	9.04%101.35M	9.95%101.9M	14.43%96.39M	13.61%95.68M
Lease liabilities	37.99%28.01M	12.67%29.68M	-13.42%27.51M	-4.69%24.42M	1.67%20.3M	42.08%26.34M	93.75%31.77M	42.20%25.62M	-1.60%19.96M	-8.17%18.54M
Other non current liabilities	-69.79%1.24M	-69.79%1.24M	-69.79%1.24M	-69.79%1.24M	0.00%4.1M	0.00%4.1M	0.00%4.1M	0.00%4.1M	0.00%4.1M	0.00%4.1M
Total non current liabilities	-38.41%153.64M	-56.69%156.07M	-63.90%156.06M	-62.99%154.07M	-45.67%249.44M	-19.67%360.34M	-13.61%432.33M	-16.95%416.25M	-16.75%459.14M	-18.75%448.55M
Total liabilities	-19.47%1.71B	-5.54%1.73B	-10.70%1.61B	-8.89%1.43B	11.52%2.12B	14.32%1.83B	27.63%1.8B	20.05%1.57B	18.53%1.9B	1.94%1.6B
Shareholders equity
Paid-in capital	20.00%1.98B	20.00%1.98B	0.00%1.65B	0.00%1.65B	0.00%1.65B	0.00%1.65B	20.00%1.65B	20.00%1.65B	20.00%1.65B	20.00%1.65B
Capital reserve funds	-11.80%2.46B	-11.80%2.46B	0.00%2.79B	0.00%2.79B	0.00%2.79B	0.00%2.79B	-8.95%2.79B	-8.95%2.79B	-8.95%2.79B	-8.95%2.79B
Surplus reserve funds	0.90%261.76M	0.90%261.76M	0.90%261.76M	0.90%261.76M	2.29%259.43M	2.29%259.43M	2.29%259.43M	2.29%259.43M	1.22%253.62M	1.22%253.62M
Retained profit	21.18%5.94B	22.56%5.61B	24.77%5.44B	25.03%5.12B	28.24%4.9B	27.03%4.58B	25.11%4.36B	21.95%4.1B	20.97%3.82B	22.73%3.61B
Other composite income	0.00%-104.21K	0.00%-104.21K	0.00%-104.21K	0.00%-104.21K	0.00%-104.21K	0.00%-104.21K	0.00%-104.21K	0.00%-104.21K	0.00%-104.21K	0.00%-104.21K
Shareholders equity without minority interests	10.84%10.64B	11.16%10.32B	11.94%10.14B	11.68%9.82B	12.74%9.6B	11.81%9.28B	10.77%9.06B	9.23%8.8B	8.48%8.52B	8.79%8.3B
Minority interests	11.42%3.21B	11.71%3.09B	14.66%3.05B	14.50%2.93B	15.25%2.88B	17.33%2.77B	17.33%2.66B	15.60%2.56B	15.45%2.5B	13.11%2.36B
Total shareholder equity	10.97%13.85B	11.28%13.41B	12.56%13.19B	12.32%12.75B	13.31%12.48B	13.03%12.05B	12.19%11.72B	10.60%11.36B	9.98%11.01B	9.72%10.66B
Total liabilityies and equity	6.56%15.55B	9.06%15.14B	9.46%14.79B	9.74%14.19B	13.05%14.6B	13.20%13.88B	14.02%13.51B	11.67%12.93B	11.16%12.91B	8.64%12.26B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

600161 Beijing Tiantan Biological Products Corporation

Beijing Tiantan Biological Products Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow